Predicting enzyme targets for cancer drugs by profiling human metabolic reactions in NCI-60 cell lines
- PMID: 20932284
- PMCID: PMC2964682
- DOI: 10.1186/1471-2105-11-501
Predicting enzyme targets for cancer drugs by profiling human metabolic reactions in NCI-60 cell lines
Abstract
Background: Drugs can influence the whole metabolic system by targeting enzymes which catalyze metabolic reactions. The existence of interactions between drugs and metabolic reactions suggests a potential way to discover drug targets.
Results: In this paper, we present a computational method to predict new targets for approved anti-cancer drugs by exploring drug-reaction interactions. We construct a Drug-Reaction Network to provide a global view of drug-reaction interactions and drug-pathway interactions. The recent reconstruction of the human metabolic network and development of flux analysis approaches make it possible to predict each metabolic reaction's cell line-specific flux state based on the cell line-specific gene expressions. We first profile each reaction by its flux states in NCI-60 cancer cell lines, and then propose a kernel k-nearest neighbor model to predict related metabolic reactions and enzyme targets for approved cancer drugs. We also integrate the target structure data with reaction flux profiles to predict drug targets and the area under curves can reach 0.92.
Conclusions: The cross validations using the methods with and without metabolic network indicate that the former method is significantly better than the latter. Further experiments show the synergism of reaction flux profiles and target structure for drug target prediction. It also implies the significant contribution of metabolic network to predict drug targets. Finally, we apply our method to predict new reactions and possible enzyme targets for cancer drugs.
Figures









Similar articles
-
Predicting new molecular targets for rhein using network pharmacology.BMC Syst Biol. 2012 Mar 21;6:20. doi: 10.1186/1752-0509-6-20. BMC Syst Biol. 2012. Retraction in: BMC Syst Biol. 2014;8:105. doi: 10.1186/s12918-014-0105-3. PMID: 22433437 Free PMC article. Retracted.
-
SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.BMC Med Genomics. 2020 Apr 3;13(Suppl 5):50. doi: 10.1186/s12920-020-0681-6. BMC Med Genomics. 2020. PMID: 32241274 Free PMC article.
-
Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.Drug Resist Updat. 2015 Nov;23:20-54. doi: 10.1016/j.drup.2015.10.003. Epub 2015 Oct 31. Drug Resist Updat. 2015. PMID: 26690339 Review.
-
Predict drug sensitivity of cancer cells with pathway activity inference.BMC Med Genomics. 2019 Jan 31;12(Suppl 1):15. doi: 10.1186/s12920-018-0449-4. BMC Med Genomics. 2019. PMID: 30704449 Free PMC article.
-
Metabolic targeting of malignant tumors: small-molecule inhibitors of bioenergetic flux.Recent Pat Anticancer Drug Discov. 2011 Jan;6(1):6-14. doi: 10.2174/157489211793980114. Recent Pat Anticancer Drug Discov. 2011. PMID: 21110820 Free PMC article. Review.
Cited by
-
Mathematical and Computational Modeling in Complex Biological Systems.Biomed Res Int. 2017;2017:5958321. doi: 10.1155/2017/5958321. Epub 2017 Mar 13. Biomed Res Int. 2017. PMID: 28386558 Free PMC article. Review.
-
Multi-target drug repositioning by bipartite block-wise sparse multi-task learning.BMC Syst Biol. 2018 Apr 24;12(Suppl 4):55. doi: 10.1186/s12918-018-0569-7. BMC Syst Biol. 2018. PMID: 29745839 Free PMC article.
-
Exploring synergies between plant metabolic modelling and machine learning.Comput Struct Biotechnol J. 2022 Apr 16;20:1885-1900. doi: 10.1016/j.csbj.2022.04.016. eCollection 2022. Comput Struct Biotechnol J. 2022. PMID: 35521559 Free PMC article. Review.
-
Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer.Nature. 2018 Apr;556(7700):249-254. doi: 10.1038/s41586-018-0018-1. Epub 2018 Apr 3. Nature. 2018. PMID: 29615789 Free PMC article.
-
CLC-Pred: A freely available web-service for in silico prediction of human cell line cytotoxicity for drug-like compounds.PLoS One. 2018 Jan 25;13(1):e0191838. doi: 10.1371/journal.pone.0191838. eCollection 2018. PLoS One. 2018. PMID: 29370280 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources